Pier Capital’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-271,848
| Closed | -$3.06M | – | 109 |
|
|
2022
Q4 | $3.06M | Sell |
271,848
-769
| -0.3% | -$8.67K | 0.5% | 88 |
|
|
2022
Q3 | $2.61M | Sell |
272,617
-125,128
| -31% | -$1.2M | 0.45% | 87 |
|
|
2022
Q2 | $3.22M | Buy |
397,745
+3,302
| +0.8% | +$26.7K | 0.55% | 80 |
|
|
2022
Q1 | $6.67M | Buy |
394,443
+93,240
| +31% | +$1.58M | 0.85% | 70 |
|
|
2021
Q4 | $6.47M | Buy |
301,203
+225,841
| +300% | +$4.85M | 0.68% | 78 |
|
|
2021
Q3 | $5.57M | Buy |
+75,362
| New | +$5.57M | 0.58% | 90 |
|